Page last updated: 2024-11-06

zopiclone and Atrophy

zopiclone has been researched along with Atrophy in 1 studies

zopiclone: S(+)-enantiomer of racemic zopiclone; azabicyclo(4.3.0)nonane; a nonbenzodiazepine; one of the so-called of Z drugs (zopiclone, eszopiclone, zolpidem, and zaleplon) for which there is some correlation with tumors; was term of zopiclone 2004-2007
zopiclone : A pyrrolo[3,4-b]pyrazine compound having a 4-methylpiperazine-1-carboxyl group at the 5-position, a 5-chloropyridin-2-yl group at the 6-position and an oxo-substituent at the 7-position.

Atrophy: Decrease in the size of a cell, tissue, organ, or multiple organs, associated with a variety of pathological conditions such as abnormal cellular changes, ischemia, malnutrition, or hormonal changes.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Katsunuma, H1
Shimizu, T1
Ogawa, K1
Kubo, H1
Ishida, H1
Yoshihama, A1

Reviews

1 review available for zopiclone and Atrophy

ArticleYear
Treatment of insomnia by concomitant therapy with Zopiclone and Aniracetam in patients with cerebral infarction, cerebroatrophy, Alzheimer's disease and Parkinson's disease.
    Psychiatry and clinical neurosciences, 1998, Volume: 52, Issue:2

    Topics: Aged; Alzheimer Disease; Atrophy; Azabicyclo Compounds; Cerebral Cortex; Cerebral Infarction; Drug T

1998